HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoshige Kino Selected Research

glucocorticoid receptor alpha

4/2006Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477H and hGRalphaG679S associated with generalized glucocorticoid resistance.
6/2005A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
4/2004Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoshige Kino Research Topics

Disease

22Glucocorticoid Receptor Deficiency
01/2018 - 04/2002
8Hypersensitivity (Allergy)
12/2015 - 12/2002
8Insulin Resistance
11/2013 - 06/2003
7Infections
01/2021 - 12/2002
6Inflammation (Inflammations)
06/2021 - 01/2003
6Cushing Syndrome
05/2014 - 04/2002
6Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013 - 06/2003
5Obesity
05/2013 - 06/2007
5Hyperandrogenism
10/2010 - 01/2004
4Lipodystrophy
09/2013 - 06/2003
4Fatigue
10/2009 - 04/2004
4Acquired Immunodeficiency Syndrome (AIDS)
06/2004 - 12/2002
3Virus Diseases (Viral Diseases)
06/2021 - 05/2011
3Hypertension (High Blood Pressure)
08/2012 - 09/2002
3Atherosclerosis
10/2009 - 10/2004
2COVID-19
06/2021 - 01/2021
2Hyperaldosteronism (Conn Syndrome)
07/2013 - 08/2012
2Hyperuricemia
01/2013 - 01/2010
2Neurodegenerative Diseases (Neurodegenerative Disease)
05/2010 - 07/2007
2Sleep Initiation and Maintenance Disorders (Insomnia)
10/2009 - 06/2007
2Essential Hypertension
10/2009 - 06/2007
2Type 2 Diabetes Mellitus (MODY)
10/2009 - 06/2007
2Osteoporosis
10/2009 - 06/2007
2Pain (Aches)
10/2009 - 06/2007
1Respiratory Insufficiency (Respiratory Failure)
06/2021
1Sepsis (Septicemia)
06/2021
1Pneumonia (Pneumonitis)
06/2021
1Communicable Diseases (Infectious Diseases)
06/2021
1Human Influenza (Influenza)
06/2021
1Pathologic Processes
01/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017
1Mood Disorders (Mood Disorder)
01/2015
1Inborn Genetic Diseases (Disease, Hereditary)
05/2014
1HIV Infections (HIV Infection)
09/2013
1Chronic Renal Insufficiency
07/2013
1Overweight
05/2013
1Cardiovascular Diseases (Cardiovascular Disease)
10/2012
1Body Weight (Weight, Body)
09/2012
1Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance)
08/2012
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Hypoglycemia (Reactive Hypoglycemia)
05/2010
1Hypokalemia
05/2010
1Starvation
02/2010
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2010
1Neoplasms (Cancer)
12/2009

Drug/Important Bio-Agent (IBA)

33GlucocorticoidsIBA
06/2021 - 06/2002
16Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
02/2016 - 06/2003
10Proteins (Proteins, Gene)FDA Link
06/2021 - 09/2002
9Hydrocortisone (Cortisol)FDA LinkGeneric
05/2014 - 04/2002
8MineralocorticoidsIBA
10/2010 - 04/2002
6Dexamethasone (Maxidex)FDA LinkGeneric
06/2021 - 04/2002
6SteroidsIBA
06/2021 - 09/2002
6LigandsIBA
05/2014 - 06/2002
5Messenger RNA (mRNA)IBA
05/2013 - 05/2009
4Insulin (Novolin)FDA Link
09/2012 - 06/2004
4AldosteroneIBA
08/2012 - 01/2004
4Adrenocorticotropic Hormone (ACTH)FDA Link
10/2010 - 04/2002
3Amino AcidsFDA Link
01/2018 - 06/2002
3Hormones (Hormone)IBA
01/2015 - 06/2004
3CytokinesIBA
05/2013 - 08/2007
3glucocorticoid receptor alphaIBA
04/2006 - 04/2004
2Transcription Factors (Transcription Factor)IBA
01/2020 - 04/2005
2vpr Gene ProductsIBA
09/2013 - 02/2008
2Citric Acid (Citrate)FDA LinkGeneric
01/2013 - 01/2010
2Allopurinol (Remid)FDA LinkGeneric
01/2013 - 01/2010
2Xanthine OxidaseIBA
01/2013 - 01/2010
2Uric Acid (Urate)IBA
01/2013 - 01/2010
2Glucose (Dextrose)FDA LinkGeneric
09/2012 - 01/2010
2AndrogensIBA
08/2012 - 04/2002
2Cyclin-Dependent Kinase 5IBA
05/2010 - 07/2007
1Immunoglobulin G (IgG)IBA
01/2021
1AntibodiesIBA
01/2021
1VaccinesIBA
01/2021
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
01/2017
1Protein Kinases (Protein Kinase)IBA
11/2013
1Adenosine Monophosphate (AMP)IBA
11/2013
1DNA (Deoxyribonucleic Acid)IBA
04/2013
1InterleukinsIBA
01/2013
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2013
1Interleukin-10 (Interleukin 10)IBA
01/2013
1Malondialdehyde (Propanedial)IBA
09/2012
1AcidsIBA
08/2012
1PotassiumIBA
08/2012
1Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
01/2012
1Phosphoenolpyruvate CarboxylaseIBA
01/2012
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
05/2011
1InterferonsIBA
05/2011
1Polymethyl Methacrylate (Sol)IBA
01/2011
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
07/2010
1Arginine (L-Arginine)FDA Link
05/2010
1Furylfuramide (AF2)IBA
05/2010
1Untranslated RNA (Noncoding RNA)IBA
02/2010
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2010
1oxidized low density lipoproteinIBA
01/2010
1Angiotensin IIIBA
01/2010
1AntigensIBA
12/2009
1Estrogen ReceptorsIBA
12/2009

Therapy/Procedure

2Therapeutics
09/2013 - 10/2004
1Critical Care (Surgical Intensive Care)
01/2021
1Adrenalectomy
07/2013